Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 612845-44-0 | MDL No. : | MFCD06201032 |
Formula : | C7H10BNO3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | UONCERAQKBPLML-UHFFFAOYSA-N |
M.W : | 166.97 | Pubchem ID : | 12012237 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.29 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 45.36 |
TPSA : | 62.58 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.01 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 0.43 |
Log Po/w (WLOGP) : | -0.84 |
Log Po/w (MLOGP) : | -0.84 |
Log Po/w (SILICOS-IT) : | -0.92 |
Consensus Log Po/w : | -0.43 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.32 |
Solubility : | 8.03 mg/ml ; 0.0481 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.31 |
Solubility : | 8.15 mg/ml ; 0.0488 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.44 |
Solubility : | 6.05 mg/ml ; 0.0362 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.23 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 163105-89-3 ]
(6-Methoxypyridin-3-yl)boronic acid
Similarity: 0.97
[ 762262-09-9 ]
(2-Methoxypyridin-4-yl)boronic acid
Similarity: 0.84
[ 871839-91-7 ]
2-Isopropoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
Similarity: 0.76
[ 1257553-85-7 ]
2-Propoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
Similarity: 0.75
[ 854373-97-0 ]
(2-Ethoxypyridin-3-yl)boronic acid
Similarity: 0.74
[ 163105-89-3 ]
(6-Methoxypyridin-3-yl)boronic acid
Similarity: 0.97
[ 762262-09-9 ]
(2-Methoxypyridin-4-yl)boronic acid
Similarity: 0.84
[ 871839-91-7 ]
2-Isopropoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
Similarity: 0.76
[ 1257553-85-7 ]
2-Propoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
Similarity: 0.75
[ 854373-97-0 ]
(2-Ethoxypyridin-3-yl)boronic acid
Similarity: 0.74
[ 163105-89-3 ]
(6-Methoxypyridin-3-yl)boronic acid
Similarity: 0.97
[ 762262-09-9 ]
(2-Methoxypyridin-4-yl)boronic acid
Similarity: 0.84
[ 871839-91-7 ]
2-Isopropoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
Similarity: 0.76
[ 1257553-85-7 ]
2-Propoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
Similarity: 0.75
[ 854373-97-0 ]
(2-Ethoxypyridin-3-yl)boronic acid
Similarity: 0.74